KRAS and rectal cancer: In a study of rectal cancer, BIK was also identified as a poor prognostic marker for microsatellite-stabilized colorectal cancer harboring KRAS mutations, and rectal cancer patients with high expression of BIK tended to have shorter survival times (Liu P. et al., 2022).